Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial

Objective: The present study compared the pharmacokinetics of two (1 mg) tacrolimus formulations (test (generic from Panacea) and reference (innovator from Astellas)) after a single-dose administration as per the European Medicine Agency (EMA) guidelines to grant marketing authorization. Materials a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Lalitendu, Bhushan, Sumit, Rüttger, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041308/
https://www.ncbi.nlm.nih.gov/pubmed/31841106
http://dx.doi.org/10.5414/CP203534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041308/
https://www.ncbi.nlm.nih.gov/pubmed/31841106
http://dx.doi.org/10.5414/CP203534

Ejemplares similares